Breaking News


Roche Talks to Illumina Rivals After Failed Bid, Sonntag Reports

Roche Holding AG (ROG) is looking for alternatives after its takeover of Illumina failed, Der Sonntag reported without saying where it got the information.

The Basel, Switzerland-based drugmaker is in talks with the research centers of three “large” universities that want to sell their gene-sequencing technologies to Roche, the Aarau, Switzerland-based newspaper said.

To contact the reporter on this story: Carolyn Bandel in Zurich at

To contact the editor responsible for this story: Frank Connelly at

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.